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The  most  abundant  lymphocyte  present  in  decidual  tissue  is  the  CD8+ T cell.  It has  been shown  that
most  decidual  CD8+ T cells  have  an effector-memory  phenotype,  but expressed  reduced  levels of perforin
and granzyme  B compared  with  the peripheral  CD8+ effector-memory  T cells.  The  speciﬁcity  of  these
CD8+ memory  T cells  has  yet to  be  determined.  One  hypothesis  is that  the  decidual  memory  T  cells  are
virus-speciﬁc  T cells that should  protect  the  fetus  against  incoming  pathogens.  As  virus-speciﬁc  CD8+
memory  T cells  can  cross-react  with  human  leukocyte  alloantigens,  an  alternative,  but  not  mutually
+ecidua
ormal pregnancy
D8+ memory T cells
irus-speciﬁc
exclusive,  hypothesis  is that these  CD8 T  cells  are  fetus-speciﬁc.  Using  virus-speciﬁc  tetramers,  we found
increased  percentages  of  virus-speciﬁc  CD8+ T cells  in  decidual  tissue  compared  with  peripheral  blood
after  uncomplicated  pregnancy.  So  far,  no  evidence  has  been  obtained  for a cross-reactive  response  of
these  virus-speciﬁc  T cells  to fetal human  leukocyte  antigens.  These  results  suggest  that  the virus-speciﬁc
memory  T cells  accumulate  in  the placenta  to protect  the  fetus  from  a harmful  infection.
© 2015  Elsevier  Ireland  Ltd.  All  rights  reserved.. Introduction
The maternal immune system has been shown to be aware of the
resence of the fetus (Aluvihare et al., 2004; Bonney and Matzinger,
997; Kahn and Baltimore, 2010; Tafuri et al., 1995). Previous stud-
es have shown that antibodies to fetal human leukocyte antigen
HLA) are produced during pregnancy (van Kampen et al., 2002; van
ood et al., 1958) and functional cytotoxic T lymphocytes speciﬁc
o fetal HLA and minor histocompatibility antigens are present in
he peripheral blood of pregnant women (Bouma et al., 1996; van
ampen et al., 2001 Verdijk et al., 2004). In addition, the prolifera-
ive responses to fetal antigens are not different during pregnancy
ompared with non-pregnant controls (Lashley et al., 2011).
Abbreviations: CMV, cytomegalovirus; EBV, Epstein-Barr virus; FBS, fetal bovine
erum; FITC, ﬂuorescein isothiocyanate; HLA, human leukocyte antigen; IFN,
nterferon; IL, interleukin; IMDM,  Iscove’s Modiﬁed Dulbecco’s Medium; LCL, lym-
hoblastoid cell lines; mPBL, heparinized peripheral blood; Nk cell, natural killer
ell; PBS, phosphate-buffered saline; PE, phycoerythrin; PHA, phytohaemagglutinin;
CB, umbilical cord blood.
∗ Corresponding author at: P.O. Box 9600 (location code: P3-24), 2300 RC Leiden,
he Netherlands. Fax: +31 71 5266741.
E-mail addresses: A.van Lochem@lumc.nl, angelave2000@gmail.com
A. van Egmond).
ttp://dx.doi.org/10.1016/j.jri.2015.09.073
165-0378/© 2015 Elsevier Ireland Ltd. All rights reserved.Previous studies in our laboratory focused on the local immune
response in the uterus during pregnancy. Activated T cells
in decidual tissue were found in uncomplicated pregnancies
(Sindram-Trujillo et al., 2003) and the percentage of CD4+CD25bright
T cells was  found to be higher in the decidua than in the periph-
eral blood (Tilburgs et al., 2006). Fetus-speciﬁc regulatory T cells
from the peripheral blood were shown to be recruited to the
fetal–maternal interface (Tilburgs et al., 2008). A proportion of
decidual T cells express HLA-C-speciﬁc killer immunoglobulin-like
receptors (KIRs) (Tilburgs et al., 2009a). Functional regulatory T
cells were only found in HLA-C mismatched pregnancies and not in
HLA-C matched pregnancies (Tilburgs et al., 2009b).
At the fetal–maternal interface the maternal immune cells come
into contact with trophoblast cells. Several studies have shown that
the trophoblast cells do not express HLA-A and HLA-B (Redman
et al., 1984), but trophoblast cells express HLA-C, HLA-G and HLA-
E on the cell surface (King et al., 1996, 2000a,b; Proll et al., 1999;
Tilburgs et al., 2015). HLA-C molecules on the surface of trophoblast
cells were only detected in beta(2) m-associated complexes, sug-
gesting a stable HLA-C complex with little degradation to free heavy
chains at the cell surface (Apps et al., 2008). The alternative HLA
expression on trophoblast cells induces CD4+ regulatory T cells and
NK cell tolerance (LeMaoult et al., 2004; Szekeres-Bartho, 2008).
However, HLA-C and HLA-E, expressed on haematopoietic stem
cells and phytohaemagglutinin (PHA) blasts respectively, have been
2 productive Immunology 113 (2016) 1–8
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Table 1
Human leukocyte antigen (HLA) molecules and viral peptides used to create
tetramers.
Virus HLA Peptide
CMV A2 NLVPMVATV
A3 TVYPPSSTAK
B7 RPHERNGFTVL
B7 TPRVTGGGAM
B35 IPSINVHHY
EBV A2 GLCTLVAML
A3 RLRAEAQVK
A3 KIRLRPGGK
A3 RVRAYTYSK
A3 KHSRVRAYTYSK
B7 RPPIFIRRL
B35 EPLPQGQLTAY
B35 HPVGEADYFEY A. van Egmond et al. / Journal of Re
hown to serve as targets for allogeneic effector T cells (Romagnani
t al., 2002; Heemskerk et al., 2005).
The most abundant type of T cell present in the decidual tissue
s the CD8+ T cell. In contrast to the peripheral blood, the decidual
issue contains a lower percentage of CD4+ T cells and a higher
ercentage of CD8+ T cells (Tilburgs et al., 2009a). The decidual
D8+ T cells were suggested to follow an alternative differenti-
tion pathway inﬂuenced by regulating cell populations, such as
D4+CD25bright T cells, shown to be present at the fetal–maternal
nterface, resulting in an altered phenotype and function (Tilburgs
t al., 2010b). The percentage of CD8+CD28− T cells was  increased
n the decidua compared with the peripheral blood (Tilburgs et al.,
006). In addition, the CD8+CD28− T cells found in the decidua
o not express the cytolytic molecule perforin (Tilburgs et al.,
009c). Further investigation showed that decidual CD8+ T cells
ere mainly of the effector-memory phenotype and that these cells
xpressed reduced levels of perforin and granzyme B compared
ith the peripheral CD8+ effector-memory T cells (Tilburgs et al.,
010a).
Tilburgs et al. (2010b) suggested that fetal alloantigens at the
etal–maternal interface might induce an antigen-speciﬁc T cell
esponse. The decidual CD8+ T cells may  directly recognize fetal
LA-C, although a correlation between the presence of an HLA-
 mismatch and the percentage of CD8+CD28− T cells in decidual
issue was not found. Another possibility could be that the decid-
al memory T cells are virus-speciﬁc T cells that should protect
he fetus from incoming pathogens. Chronically persisting viruses
uch as the Epstein-Barr virus (EBV) and cytomegalovirus (CMV)
re known to induce high frequencies of memory T cells (D’Orsogna
t al., 2010). These virus-speciﬁc CD8+ memory T cells commonly
ross-react with allogeneic HLA class I molecules (Amir et al.,
010), a phenomenon called heterologous immunity. We  therefore
ypothesize that the virus-speciﬁc decidual CD8+ memory T cells
ight potentially be cross-reactive with the mismatched HLA of
he fetus.
So far, the speciﬁcity of the memory T cells found in decid-
al tissue is unknown. The aim of this study was  to investigate
he speciﬁcity of the CD8+ memory T cells in decidual tissue. The
ercentage of virus-speciﬁc CD8+ T cells was determined for lym-
hocytes isolated from the decidua basalis, decidua parietalis, and
eripheral blood after uncomplicated pregnancy. In addition, T
ell clones and cell lines were generated to investigate the pos-
ible alloreactivity against the paternal HLA-C expressed on the
rophoblast.
. Materials and methods
.1. Tissue samples and lymphocyte isolation
Paired samples of decidua basalis, decidua parietalis, and hep-
rinized peripheral blood (mPBL) were collected from healthy
omen after an uncomplicated term pregnancy. In addition, umbil-
cal cord blood (UCB) was collected. Tissue samples were obtained
fter delivery by elective caesarean section. Decidual lymphocytes
ere isolated according to our standard protocol, as described pre-
iously (Tilburgs et al., 2006). In short, the decidua basalis and
ecidua parietalis were macroscopically dissected from the pla-
enta or membranes and washed in phosphate-buffered saline
PBS). The tissue was minced and washed again to reduce con-
amination with blood and trophoblast cells. Decidual tissue was
hen incubated for an hour with 0.2% collagenase I and 0.02%
eoxyribonuclease I in RPMI 1640 (Gibco, Paisley, Scotland) in a
ater bath (37 ◦C, gently shaking). The decidual fragments were
ashed in RPMI, ﬁltered through a 70-m sieve (Becton Dick-
nson Labware, Franklin Lakes, NJ, USA) and washed again. TheB35 MGSLEVMPM
B35 YPLHEQHGM
B35 AVLLHEESM
decidual isolates were layered on a Percoll gradient (10 ml
1.080 g/ml; 12.5 ml  1.053 g/ml; 20 ml  1.023 g/ml) for density gradi-
ent centrifugation (30 min/800 × g) and lymphocytes were isolated
from the 1.080 g/ml–1.053 g/ml interface. Cells were washed twice
and counted. Blood (mPBL and UCB) was layered on a Ficoll-
Hypaque (LUMC pharmacy, Leiden, The Netherlands) for density
gradient centrifugation (20 min/800 × g). Mononuclear cells were
collected, washed twice with PBS and counted. The cells were
frozen and stored in liquid nitrogen until analysis. HLA typing of the
mother was  performed at the typing laboratory of the Leiden Uni-
versity Medical Center using sequence-speciﬁc oligonucleotides
(SSO) PCR.
2.2. Flow cytometric analysis
Two-colour immunoﬂuorescence staining was  performed to
investigate tetramer-positive CD8+ T cells. An allophycocyanin-
conjugated CD8 antibody (Becton Dickinson) was used in
concentrations according to the manufacturer’s instructions to
stain the CD8+ lymphocytes. The speciﬁcity of these cells was
examined by staining the cells with a mixture of phycoerythrin
(PE)-conjugated HLA class I/peptide complexes. The tetrameric
complexes used in this study were constructed as previously
described (Burrows et al., 2000). Table 1 shows a list of the
tetrameric complexes used in this study. Cells were stained for
30 min  at 4 ◦C and washed in PBS (LUMC pharmacy) with 5%
fetal bovine serum (FBS; Greiner Bio-One B.V., Alphen a/d Rijn,
the Netherlands). Flow cytometric analysis was  performed using
a Calibur ﬂow cytometer with Cellquest Pro software (Becton Dick-
inson). The data were analysed using the gating strategy shown
in Fig. 1a. First, the lymphocyte gate was set around the viable
lymphocytes and the CD8+ T cells were selected. The percentage
of tetramer-positive cells was  determined within the CD8+ T cell
population.
2.3. Generation of virus-speciﬁc CD8+ T-cell clones and cell lines
The lymphocytes isolated from the decidua basalis, decidua
parietalis, and the peripheral blood were prepared for sorting as
described before (Heemskerk et al., 2004). In short, cells were
stained with a mixture of tetrameric complexes and antibodies
directed against various cell surface molecules for 30 min at 4 ◦C
in Iscove’s Modiﬁed Dulbecco’s Medium (IMDM) without phenol
(Lonza/Biowhittaker), supplemented with 2% FBS. The antibod-
ies used were ﬂuorescein isothiocyanate (FITC)-conjugated and
directed against CD4, CD19, CD14, CD40, CD16, and CD56 (Bec-
ton Dickinson). The cells were washed and cell sorted at 4 ◦C using
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Fig. 1. Gating strategies. (a) Lymphocytes were stained for CD8 and a mixture of tetrameric complexes according to the maternal human leukocyte antigen (HLA) typing.
The  lymphocyte gate was  set around the viable lymphocytes and the CD8+ T cells were selected. The percentage of tetramer-positive cells was determined within the CD8+
T cell population. (b) Lymphocytes were stained for CD4, CD19, CD14, CD40, CD16, CD56 and a mixture of tetrameric complexes according to the maternal HLA typing.
The  lymphocyte gate was  set around viable lymphocytes and cell doublets were excluded. The cells positive for the mixture of tetrameric complexes, but negative for the
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uforementioned surface markers (dump-FITC), were sorted into 96-well plates. (c) 
ines  generated after sorting using a mixture of tetrameric complexes. The tetrame
etramer complexes from the mixture separately.
he ﬂuorescence-activated cell sorter Aria Sorp (Becton Dickinson).
ig. 1b shows the gating strategy used to sort tetramer-positive
ells. Cells that were negative for the cell surface molecules and
ositive for the mixture of tetramers were sorted and cultured at 1
ell/well (clones) or 10 cells/well (cell lines). The cells were sorted
nto a 96-well plate containing a feeder cell mixture with irradiated
llogeneic PBMCs (4000 rad), 800 ng/ml PHA, 10 IU/ml IL-2 in IMDM
upplemented with glutamine (Gibco), human serum (5%) and FBS
5%). Thereafter, sorted cells were non-speciﬁcally stimulated every
wo weeks with freshly prepared feeder cell mixtures. CD8 and
etramer positivity was  conﬁrmed by ﬂow cytometric analysis, as
escribed above, when clones and/or cell lines started to expand
Fig. 1c). In addition, the mono- or polyclonality of the generated T
ell clones and cell lines was conﬁrmed by determining the TCR V
sage with the TCR V repertoire kit (Beckman Coulter).
.4. Cytokine assaysA panel of EBV-transformed B cells (EBV LCLs) selected to cover
he most frequently occurring HLA class I and II molecules were
sed to screen for allo-HLA cross-reactivity. In addition, mononu-gure shows a representative example of the ﬂow cytometric analysis of clones/cell
itivity of the generated clones and cell lines was investigated by staining with the
clear cells isolated from the umbilical cord blood of the women’s
own child were used to investigate a possible fetus-speciﬁc allo-
response. Supernatants were collected 18 h after co-cultures with
10,000 virus-speciﬁc T cells and 50,000 irradiated stimulator cells
(EBV LCLs or umbilical cord blood cells) in a ﬁnal volume of 150 l
IMDM culture medium supplemented with 10% FBS and 100 IU/ml
IL-2. The concentration of IFN- was determined in these super-
natants using a Th1/Th2 kit (Bio-Rad).
2.5. Cytotoxicity assays
Cell-mediated lympholysis was used to analyse the cytotoxic
capacity of the generated T cell clones (effector) towards the UCB of
the women’s own  child (target). Maternal peripheral blood leuko-
cytes, third party UCB with expression of HLA-A*29 and an EBV
LCL with expression of HLA-A*02 (with or without the addition
of the A2-EBV-GLC peptide) were used as target cell controls. The
cytotoxic capacity of the effector cells was  analysed in triplicate
using four effector:target ratios (1:1, 5:1, 10:1 and 20:1). The tar-
get cells were labelled with 51Cr, added to the effector cells in
round-bottomed 96-well plates and incubated at 37 ◦C in a humid-
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Table 2
Pregnancy characteristics (n = 6).
Pregnancy
Gestational age (days) 274 (269–278)
Indication caesarean section
-  Breach presentation 1 (17%)
-  Caesarean previous pregnancy 3 (50%)
-  Obstetric history 2 (33%)
Anaesthesia (caesarean section)
- Combined spinal epidural 6 (100%)
Mother
Age  (years) 32 (29–36)
Highest diastolic pressure (mmHg) 80 (65–95)
Gravidity 2 (1–3)
Parity 1 (0–2)
CMV  seropositive 2 (33%)
EBV  seropositive 5 (83%)
Child
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Table 3
Maternal HLA-A and -B typing.
Pregnancy A-locus B-Locus
1 A*02 B*07 B*27
2  A*02 A*33 B*14 B*44
3  A*02 A*11 B*07 B*15
4  A*03 A*11 B*35 B*55
5  A*02 A*68 B*35 B*40
6  A*02 A*66 B*41 B*44Birth weight (g) 3932 (3500–4510)
Gender (male) 3 (50%)
ﬁed atmosphere containing 5% CO2. After incubating for 4 h, the
1Cr that was released from the target cells was measured in the
upernatant of the culture using a gamma  counter (PerkinElmer,
altham, MA,  USA).
The percentage of speciﬁc lysis was calculated using sponta-
eous and maximal lysis, by incubating the target cells for 4 h in
edium or 1% Triton X-100 respectively. The measured lysis was
ivided by the maximal lysis after correcting for the spontaneous
ysis.
.6. Statistical analysis
All statistical analyses were performed using GraphPad Prism
version 5.00 for Windows, GraphPad Software, San Diego, CA,
SA). The Friedman test was used as a non-parametric one-way
nalysis of variance for matched observations to compare the per-
entage of CD8+ T cells and the percentage of tetramer-positive
D8+ T cells within decidua basalis, decidua parietalis and mPBL.
ost-hoc analysis was performed using the Wilcoxon matched pairs
est when a statistically signiﬁcant difference was found among the
hree groups. p values < 0.05 were considered to denote signiﬁcant
ifferences.
. Results
Lymphocytes from the decidua basalis, decidua parietalis and
eripheral blood were collected from six healthy women after
ncomplicated term pregnancy. Table 2 shows the characteristics
f the pregnancies included.
.1. Validating staining with a mixture of tetrameric complexes
The lymphocytes isolated from the decidua basalis, decidua
arietalis and peripheral blood were stained with a mixture of
etrameric complexes rather than individual tetramers because of
he low cell numbers of lymphocytes that can be isolated from
ecidual tissue. To rule out the possible introduction of false-
ositive CD8+ T cells by staining with a mixture of tetrameric
omplexes instead of single tetrameric complexes, we  validated
he use of these mixtures with lymphocytes isolated from the
eripheral blood of non-pregnant individuals. The peripheral blood
f the selected individuals had previously been screened for the
resence of virus-speciﬁc CD8+ T cells with single tetrameric com-
lexes and was found to harbour CD8+ T cell populations with
everal virus speciﬁcities. In this study, the observed percentages
f virus-speciﬁc CD8+ T cells when using the mixture of tetramericThe HLA restriction of the tetrameric complexes used in the mixture are shown in
bold.
complexes were compared with the expected percentages calcu-
lated by adding up the percentages of virus-speciﬁc CD8+ T cells
stained with single tetrameric complexes (Fig. 2). The observed
percentages determined after staining with mixtures containing
three to eleven tetrameric complexes were similar to the expected
percentages in four non-pregnant individuals.
3.2. Increased percentage of virus-speciﬁc CD8+ T cells in
decidual tissue
The lymphocytes isolated from the decidua basalis, decidua
parietalis and peripheral blood were stained for CD8 and a mix-
ture of tetrameric complexes according to maternal HLA typing.
Table 3 shows the maternal HLA-A and -B typing for each pregnancy
included in this study.
Paired analysis of the decidua basalis, decidua parietalis and
peripheral blood was  used to investigate the percentage of CD8+
T cells and the virus speciﬁcity of these cells. Fig. 3a shows that the
CD8+ T cells were found to be more abundant in the decidua basalis
and decidua parietalis than in the peripheral blood (Friedman test,
p = 0.029). In addition, the percentage of tetramer-positive CD8+
T cells was  signiﬁcantly different comparing the decidua basalis,
decidua parietalis and peripheral blood (Fig. 3b; Friedman test,
p = 0.002). A signiﬁcantly higher percentage of virus-speciﬁc CD8+
T cells was  observed in both the decidua basalis and the decidua
parietalis compared with mPBL.
3.3. Virus-speciﬁc CD8+ T cell clones and cell lines
To generate virus-speciﬁc CD8+ T cell clones and cell lines,
isolated lymphocytes that stained negative for the cell surface
molecules CD4, CD19, CD14, CD40, CD16 and CD56 and posi-
tive for the mixture of tetramers were sorted. In only 20% (1/5
pregnancies) expansion of the sorted cells was possible using an
approach that had previously been validated in non-pregnant indi-
viduals. The mixture of tetrameric complexes used in this case
contained two HLA-A2 restricted tetramers with either a CMV- or
EBV-derived peptide. Although the percentage of tetramer-positive
CD8+ T cells was signiﬁcantly higher in the decidua basalis and
decidua parietalis compared with peripheral blood, the genera-
tion of clones and/or cell lines from the decidual tissue was more
difﬁcult than from peripheral blood. Not only the success rate of
generating tetramer-positive T cell clones (20% versus 100%), but
also the number of T cell clones generated from the decidua basalis,
decidua parietalis and peripheral blood collected after uncompli-
cated pregnancy (median number 0.0; n = 14) was signiﬁcantly
lower compared with the number of T cell clones generated from
peripheral blood collected from non-pregnant individuals (median
number 4.2; n = 8; p < 0.0001).
The expanding clones and cell lines generated from the decidua
basalis, decidua parietalis and peripheral blood were examined for
CD8 and tetramer positivity. Fig. 1c shows an example of cells
checked for CD8 and a single tetramer. All clones and cell lines
generated from the decidua basalis, decidua parietalis and periph-
A. van Egmond et al. / Journal of Reproductive Immunology 113 (2016) 1–8 5
Fig. 2. Validation of staining with a mixture of tetrameric complexes. The percentage of virus-speciﬁc CD8+ T cells was determined in the peripheral blood of four non-
pregnant individuals (donors A–D). The observed percentages represent the values measured after staining with a mixture of tetrameric complexes. The expected percentages
were  calculated by adding up percentages after staining with single tetrameric complexes. The mixtures contained three to eleven tetrameric complexes, based on the HLA
typing  of the donor.
Fig. 3. Increased percentage of CD8+ and CD8+Tetramer+ T cells in decidual tissue compared with peripheral blood. (a) The lymphocytes isolated from decidual tissue and
peripheral blood were stained for CD8. The percentage of CD8+ T cells was  determined
a  mixture of tetrameric complexes according to the maternal HLA typing. The percenta
Percentages are shown as mean values ± SEM. p values < 0.05 were considered to denote 
Table 4
V usage of the generated T cell clones and cell lines. # = not determined,
mPBL = heparinized peripheral blood.
Tissue Code Clone/cell line V
Decidua basalis A6 Clone Clone V2
G2 Clone V2
C1 Cell line V1
C7 Cell line V1
C8 Cell line V2+V9
Decidua parietalis A11 Clone V4
mPBL A3 Clone V16
B12 Cell line #
e
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tB1  Cell line V13.2
C2 Cell line V3+V5.1
ral blood were positive for the A2-EBV-GLC tetramer only. The
henotype of the T cell clones generated was shown to be of the
ffector-memory phenotype (CD8+CD45RA−CCR7−; Fig. 4a and b).
etramer positivity within these CD8+ T cell subsets was not dif-
erent when comparing the decidua basalis and decidua parietalis
ith peripheral blood (data not shown). The V usage was deter-
ined for the virus-speciﬁc T cell clones and cell lines (Table 4). The
 used by T cell clones and cell lines generated from the decidua
asalis and decidua parietalis were different from those used by T
ell clones and cell lines generated from peripheral blood.
.4. Cytotoxicity of generated T cell clonesThe CD8+ T cell clones were analysed for their cytotoxic capacity
owards UCB. None of the T cell clones tested showed cytotoxicity
owards UCB in the cell-mediated lympholysis assay nor did these within the lymphocyte gate (Fig. 1a). (b) Lymphocytes were stained for CD8 and
ge of tetramer-positive cells was determined within the CD8+ T cell population.
signiﬁcant differences.
respond to UCB by producing IFN- (Fig. 4c). In contrast, signiﬁ-
cant cytotoxic responses were found towards maternal peripheral
blood leukocytes and EBV-LCLs when these target cells were loaded
with the HLA-A2-restricted EBV-GLC peptide before the incuba-
tion period (Fig. 4d and e). Fig. 4 also shows the expression of the
cytolytic molecules perforin (Fig. 4 g) and granzyme B (Fig. 4 h) for
the CD8+ T cell clones generated from the decidua parietalis.
3.5. Allo-HLA cross-reactivity by A2-EBV-GLC-speciﬁc T cell
clones
Cross-reactivity to alloantigens was tested on the basis of IFN-
production by stimulating the T cell clones with a panel of EBV LCLs,
selected to cover the most frequently occurring HLA molecules
(Fig. 4c). The T cell clone generated from the decidua parietalis
produced IFNγ upon recognition of HLA-A*02 expressing EBV LCLs
loaded with exogenous GLC peptide (Pos ctrl) and some of the EBV
LCLs expressing HLA-A*02 without the addition of exogenous GLC
peptide, but did not produce IFN- when cultured in IL-2 contain-
ing medium alone (Neg ctrl). This A2-EBV-GLC-speciﬁc T cell clone
also produced IFN- when stimulated with the HL-A*02-negative
EBV LCLs 3 and 9. These EBV LCLs shared HLA-A*29, which was  not
expressed on any other EBV LCL. In addition, this T cell clone also
showed a cytotoxic response towards a third party UCB express-
ing HLA-A*29 (Fig. 4f). Although we  found that the CD8+ T cells
did express FasL (Fig. 4i), blocking the Fas–FasL interaction in the
cytotoxicity assay did not result in a decreased cytotoxic response
towards the HLA-A*29-expressing third party UCB or target cells
presenting the A2-EBV-GLC peptide (data not shown).
In contrast, the A2-EBV-GLC-speciﬁc T cell clones generated
from the decidua basalis did not show a clear pattern of allo-
6 A. van Egmond et al. / Journal of Reproductive Immunology 113 (2016) 1–8
Fig. 4. Allo-HLA-A*29 cross-reactivity by the A2-EBV-GLC-speciﬁc memory T cell clone generated from the decidua parietalis. The phenotype of the CD8+ T cells was analysed
using  antibodies directed against CD45RA, CCR7, CD27 and CD28. The CD8+ T cell population analysed for (a) CD8+ T cells isolated from the decidua parietalis and (b) CD8+
T cell clones generated from the decidua parietalis are shown in this ﬁgure. Although the CD8+ T cells isolated from the decidua parietalis showed diversity in CD8 subsets,
the  CD8+ T cell clone generated from the decidua parietalis was  mainly of the effector-memory phenotype (CD8+CD45RA−CCR7−). (c) The T cell clone was stimulated with a
panel  of EBV LCLs, selected to cover the most common HLA molecules. After 24 h the IFN- production was measured in the culture supernatant. The T cell clone produced
IFN-  in response to EBV LCL 3 and 9, which shared expression of the HLA-A*29 molecule, not expressed by other EBV LCLs. The T cell clones were also co-cultured with
either  maternal peripheral blood leukocytes (d) or an HLA-A*02 expressing EBV-LCL (e) with (+ peptide) or without (- peptide) loading the cells with the A2-EBV-GLC peptide
before incubation. (f) In addition, we found a cytotoxic response towards third-party umbilical cord blood cells presenting HLA-A*29, but not towards the umbilical cord
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LA cross-reactivity, whereas the A2-EBV-GLC-speciﬁc T cell clones
enerated from maternal peripheral blood did not produce IFN-
n response to any of the EBV LCLs.
. Discussion
To our knowledge, this is the ﬁrst human study investigating
he speciﬁcity of CD8+ T cells in the decidua basalis and decidua
arietalis. We  found a signiﬁcantly higher percentage of virus-
peciﬁc CD8+ T cells in the decidua basalis (1.3%) and decidua
arietalis (2.2%) compared with peripheral blood (0.5%). During
urine pregnancy normal T cell responses were found following
rimary infection, including a signiﬁcant inﬁltration of CD8+ T cells
o the fetal–maternal interface (Constantin et al., 2007). In addi-
ion, in human pregnancy a dynamic maternal T cell response was
etected with a peak in expanding T cell clones during the sec-
nd trimester and normal levels before parturition (Hoger et al.,
996). Although it is not clear whether these virus-speciﬁc CD8+ T
ells migrate from the peripheral blood to the decidual tissue or are
ocally activated, our results suggest that these cells are present in
he decidual tissue to protect the fetus from harmful infections.
In previous studies, pregnancy was shown to affect CMV- and
BV-speciﬁc immune responses in different ways. The antigen-
peciﬁc immune response towards EBV was found to be suppressed
uring pregnancy (Nakamura et al., 1993), whereas no effect of
regnancy on the immune response to CMV  was observed (Revello
t al., 2006). Actually, Lissauer et al. (2011) found an accumula-
ion of CMV-speciﬁc memory cells during pregnancy. In the present
tudy we found a higher number of virus-speciﬁc T cells in the
ecidua, but the generation of clones and/or cell lines from these
etramer-positive cells was very difﬁcult. In only 20% of the preg-he expression of the cytolytic molecules perforin (g) and granzyme B (h) are shown
s-L (CD95L) of the CD8+ T cell clones generated from the decidua parietalis is also
nancies from which the tetramer-positive CD8+ T cells were sorted
from the decidua basalis, decidua parietalis and peripheral blood
could the cells be expanded. This success rate is signiﬁcantly dif-
ferent from those of previous studies (Amir et al., 2010; D’Orsogna
et al., 2009, 2010), which showed that in all cases clones and/or
cell lines can be generated when tetramer-positive CD8+ T cells are
found in the peripheral blood of non-pregnant healthy subjects.
These results suggest that during pregnancy the CD8+ T cells might
have different characteristics compared with CD8+ T cells in non-
pregnant individuals, conﬁrming previous studies describing the
alternative phenotype of the decidual CD8+ cytotoxic T cells.
In the current study, lymphocytes isolated from the periph-
eral blood and decidual tissues were stained with a mixture of
tetrameric complexes. In contrast to a previous study in which
tetrameric complexes were labelled with different ﬂuorescent dyes
to detect and enrich several T cell speciﬁcities in a single sample
(Newell et al., 2009), all available tetrameric complexes in our study
were PE-conjugated. To rule out false-positive CD8+ T cells, we
compared single tetramer stainings with the mixture of tetrameric
complexes. The percentages of tetramer-positive CD8+ T cells of the
single tetramer stainings were added up to determine the expected
percentage of tetramer-positive CD8+ T cells. The expected percent-
age was not different from that found for the mixture of tetrameric
complexes.
The distribution of CD8+ T cell subsets in decidual tissues is
different from that of peripheral blood (Tilburgs et al., 2010a).
In line with these observations, the CD8+ T cells in the decidual
tissue collected in the present study were mainly of the effector-
memory phenotype (CD8+CD45RA−CCR7−; Fig. 4a and b), whereas
the peripheral blood mainly contained naive CD8+ T cells. Tetramer
positivity within these CD8+ T cell subsets was not different
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hen comparing the decidua basalis and decidua parietalis with
eripheral blood. These observations suggest that the increased
ercentage of virus-speciﬁc CD8+ T cells in the decidua basalis and
ecidua parietalis compared with peripheral blood might be due
o the different composition of CD8+ T cell subsets in these tissues.
he effector-memory cells found in the decidua basalis and decidua
arietalis hardly express the effector molecule perforin and only
ow levels of granzyme B compared with peripheral blood (Fig. 4 g
nd h). In addition, the virus-speciﬁc T cell clones generated from
he decidual tissues were considered EM-3CD8+ T cells based on the
ack of CD45RA, CCR7, CD27 and CD28 expression (Fig. 4a and b). In
ine with previous ﬁndings (Tilburgs et al., 2010a), these EM-3CD8+
 cells did not express perforin and reduced levels of granzyme B,
gain conﬁrming the alternative phenotype of decidual CD8+ T cells.
The HLA alloreactivity by virus-speciﬁc memory T cells was
hown to be common (Amir et al., 2010). The EBV-speciﬁc T cell
lone, which we could generate from the decidua basalis and
ecidua parietalis, showed allo-HLA cross-reactivity against HLA-
*29 and was able to lyse HLA-A29-positive allogeneic cells. A
ossible mechanism for the cytotoxic response, despite the low
xpression of perforin and granzyme B, could be FasL-Fas interac-
ion. FasL-Fas interaction results in the elimination of pathogens
y inducing apoptosis in the target cell, thereby limiting tissue
amage and preserving the placenta. However, we  did not ﬁnd
 decreased cytotoxic response toward the HLA-A*29-expressing
hird party UCB or target cells presenting the A2-EBV-GLC peptide
hen the FasL–Fas interaction was blocked. An alternative expla-
ation might be that speciﬁc activation of the clone leads to the
nduction of granzyme and granzyme-mediated lysis. As the fetal
LA did not include HLA-A*29, the current data do not support
he hypothesis that these tetramer-positive T cells might be fetus-
peciﬁc, but suggest that these memory T cells are more likely to
e present in the decidua basalis and decidua parietalis to protect
he fetus from a virus infection. The virus-speciﬁc CD8+ memory T
ells investigated in this study only kill virus-infected cells express-
ng HLA-A and/or HLA-B and fetal trophoblast cells do not express
hese HLA molecules.
Therefore, immune surveillance will mainly be focused on
aternal cells in the placenta, indirectly protecting the fetus. How-
ver, if these cells pass the placenta barrier, these chimeric cells
ay  also react to the maternal HLA on the fetal cells. So far, we
ere not able to investigate virus-speciﬁc CD8+ memory T cells
hat could potentially kill virus-infected cells that express HLA-
, as HLA-C tetramers were not available. Future studies, using
unctional assays, may  determine whether HLA-C-restricted virus-
peciﬁc CD8+ memory T cells are present in the decidual tissues.
Taken together, our data suggest that in uncomplicated preg-
ancy the presence of virus-speciﬁc CD8+ T cells in the decidua
ight protect the fetus from a harmful infection. Whether these
ells are already present in early pregnancy remains to be deter-
ined. Furthermore, it cannot be excluded that these CD8+ T cells
ave different characteristics in pregnancies complicated by pre-
clampsia. Pre-eclampsia is predominated by Th1 immunity, with
n increase in the production of Th1 cytokines, which induce
nﬂammation (Saito et al., 2007). In pregnancies complicated by
re-eclampsia the virus-speciﬁc CD8+ T cells may be more prone
o eliciting fetus-speciﬁc alloresponses because of the skewing
owards Th1 immunity. Although the proportion of peripheral
lood CD8+ T cells was comparable in women with pre-eclampsia
nd healthy controls (Moore et al., 1983; Toldi et al., 2008), the
ercentage of decidual CD8+ T cells was shown to be increased in
lacentas of pre-eclamptic women compared with healthy controls
Quinn et al., 2011; Stallmach et al., 1999). In addition, the cyto-
oxic T cell response to paternal antigens was higher in women
ith pre-eclampsia than in women with uncomplicated pregnan-
ies (de Groot et al., 2010). The expression of HLA-G was reducedctive Immunology 113 (2016) 1–8 7
in pre-eclampsia compared with normal pregnancy, resulting in
an increased generation of CD8+ T cell alloresponses (Kapasi et al.,
2000). However, whether these virus-speciﬁc CD8+ T cells con-
tribute to this increased alloresponse remains to be established.
5. Conclusion
The percentage of virus-speciﬁc T cells was  found to be increased
in the decidua basalis and decidua parietalis, suggesting an accu-
mulation of memory T cells in the placenta to protect the fetus from
a harmful infection. The list of tetrameric complexes used in this
study does not cover the total number of possible speciﬁcities of the
memory T cells found in either the peripheral blood or the decidual
tissue. More extensive studies including more virus-speciﬁc T cells
are necessary to establish their role in uncomplicated pregnancy
and in pregnancy complications.
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